Amoxicillin Market is Expected to Clock a Notable A CAGR of 1.30% and Reach USD 5,072.9 Million by 2028
Market Overview: The global Amoxicillin Market is anticipated to exhibit a growth rate of 1.30%, moving from USD 4,570.5 Million in 2020 to USD 5,072.9 Million by 2028. Amoxicillin, available under the brand name Amoxil, is a generic drug used primarily for treating bacterial infections. It belongs to the β-lactam antibiotics drug class. The increase in bacterial infections worldwide, particularly in developing and low-income countries, is a major driver for the growing demand for Amoxicillin, thus fueling the Amoxicillin drug market.
Market Players: Key market players include JAMP Pharma
Corporation, Novartis, Dr. Reddy's Laboratories, Sun Pharmaceuticals,
Proficient Rx LP, Sanis Health Inc, Nucare Pharmaceuticals, Inc., Northwind
Pharmaceuticals, A-S Medication Solutions, Bryant Ranch Prepack, and others.
These players have adopted various strategies to enhance their market presence.
Start-up and Deals Landscape: Start-ups, like Alvotech, are
entering the market with innovative products and technologies. Mergers and
acquisitions continue to shape the industry, with companies like JAMP Pharma
partnering with Alvotech to commercialize biosimilar medicines in Canada.
Amoxicillin antibiotics received FDA approval in the 1980s
and have since been employed in treating various diseases. They are
particularly effective in treating bacterial pneumonia in children, as well as
urinary tract infections, sinusitis, pneumonia, ear infections, bronchitis, and
skin infections. Presently, the combination of amoxicillin and
amoxicillin-clavulanate potassium is commonly used to treat these ailments,
contributing to the expected growth of the Amoxicillin drug market.
Get a sample copy of the Amoxicillin Market report: https://www.reportsanddata.com/download-free-sample/2151
The drug is generally considered safe, with clinical trials
revealing mild side effects such as nausea, diarrhea, vomiting, and rashes when
used in combination drugs. However, these side effects may affect the market
growth. Notably, amoxicillin should not be administered to patients allergic to
penicillin antibiotics or amoxicillin, posing a potential constraint to market
expansion.
Regional Outlook: North America is poised to experience the
highest market growth due to increased investments in clinical trials and
research and development (R&D). Europe follows, with the Asia Pacific
projected to exhibit the highest compound annual growth rate (CAGR) due to a
large population at high risk of bacterial infections caused by poor hygiene and
inadequate access to clean drinking water. Latin America, the Middle East, and
Africa also face increased risks of bacterial infections due to poor sanitation
and lack of safe water sources.
Bacterial Resistance: Reports from the World Health
Organization suggest rising antibiotic resistance in both low and high-income
countries. The Global Antimicrobial Surveillance System (GLASS) indicates a
high risk of severe bacterial infections due to widespread antibiotic
resistance across 22 countries.
Market Dynamics: The Amoxicillin market is characterized by
ongoing medical advancements and research and development efforts. Leading and
emerging companies are actively pursuing both organic and inorganic growth
strategies, including agreements, partnerships, collaborations, mergers,
acquisitions, expansions, and joint ventures.
Form Overview: The Amoxicillin dosage form of 250mg is
gaining prominence, aligning with WHO's revised childhood pneumonia treatment
guidelines. Efforts are being made to ensure its availability in
limited-resource settings.
Infection Type and Distribution Channels: Amoxicillin is
utilized to treat a wide range of bacterial infections, such as chest
infections, urinary tract infections, and dental abscesses. Hospitals play a
significant role in dispensing antibiotics, particularly for chest and ear
infections, while retailers sell a substantial number of Amoxicillin products.
Expert Insights: Industry experts anticipate increased
adoption of Amoxicillin due to technological advancements and the entry of new
manufacturers. Emerging nations are expected to focus on scientific research,
driving industry growth. Platform-centric drugs and advanced technologies are
poised to reduce complexity and operational costs, further advancing the
industry.
Segments Covered: The report segments the Amoxicillin market
based on infection type, form, route of administration, distribution channels,
and region, providing revenue forecasts and analysis of market trends.
- Infection
Type Outlook
- Skin
Infections
- ENT
(Ear, Nose & Throat) Infections
- Stomach
Infections
- Lungs
Infections
- Urinary
tract infections (UTI)
- Pneumonia
- Bronchitis
- Gonorrhea
- Route
of Administration Outlook
- Oral
- Intravenous
- Form
Outlook
- Tablets
- Capsule
- Suspensions
- Syrup
- Powder
- Distribution
Channels Outlook
- Hospitals
Pharmacies
- Retail
Pharmacies
- Online
Pharmacies
- Others
- Regional
Outlook
- North
America
- U.S
- Canada
- Europe
- Germany
- U.K
- France
- BENELUX
- Rest
of Europe
- Asia
Pacific
- China
- Japan
- South
Korea
- Rest
of APAC
- Latin
America
- Brazil
- Rest
of LATAM
- MEA
- Saudi
Arabia
- UAE
- Rest
of MEA
Explore Trending Reports:
Chemical
Surface Treatment Market-https://www.globenewswire.com/news-release/2019/09/10/1913572/0/en/Chemical-Surface-Treatment-Market-To-Reach-USD-17-84-Billion-By-2026-Reports-And-Data.html
Polyvinyl
Chloride (PVC) Market-https://www.globenewswire.com/news-release/2020/02/13/1984885/0/en/Polyvinyl-Chloride-PVC-Market-To-Reach-USD-88-02-Billion-By-2027-Reports-And-Data.html
Aerosol
Propellants Market-https://www.globenewswire.com/news-release/2020/07/08/2059457/0/en/Aerosol-Propellants-Market-To-Reach-USD-12-06-Billion-By-2027-Reports-and-Data.html
Oil Spill
Management Market-https://www.globenewswire.com/en/news-release/2021/01/11/2156379/0/en/Oil-Spill-Management-Market-to-Reach-Value-of-USD-192-06-Billion-By-2027-Reports-and-Data.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/2151
Thank
you for reading our report. To know more about the customization or any query
about the report contents, please connect with us and our team will ensure the
report is tailored to meet your requirements.
About Reports and Data
Reports
and Data is a market research and consulting company that provides syndicated
research reports, customized research reports, and consulting services. Our
solutions purely focus on your purpose to locate, target, and analyse consumer
behaviour shifts across demographics, across industries, and help clients to
make smarter business decisions. We offer market intelligence studies ensuring
relevant and fact-based research across multiple industries, including
Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently
update our research offerings to ensure our clients are aware of the latest
trends existent in the market. Reports and Data has a strong base of
experienced analysts from varied areas of expertise. Our industry experience
and ability to develop a concrete solution to any research problems provides
our clients with the ability to secure an edge over their respective
competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Comments
Post a Comment